Status: current, Defined. Date: 30-Apr 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3921191000168116 | Naltrexone (Apo) (naltrexone hydrochloride 50 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3921201000168118 | Naltrexone (Apo) 50 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Naltrexone (Apo) 50 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Naltrexone (Apo) 50 mg tablet | Is a | naltrexone hydrochloride 50 mg tablet | true | Inferred relationship | Some | ||
| Naltrexone (Apo) 50 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Naltrexone (Apo) 50 mg tablet | Is a | Naltrexone (Apo) | true | Inferred relationship | Some | ||
| Naltrexone (Apo) 50 mg tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Naltrexone (Apo) 50 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1851625108 | |
| Naltrexone (Apo) 50 mg tablet | has intended active ingredient | naltrexone | true | Inferred relationship | Some | 1851625107 | |
| Naltrexone (Apo) 50 mg tablet | has Australian BoSS | naltrexone hydrochloride | true | Inferred relationship | Some | 1851625107 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Naltrexone (Apo) 50 mg tablet, 30, bottle | has TPUU | True | Naltrexone (Apo) 50 mg tablet | Inferred relationship | Some | 1 |
| Naltrexone (Apo) 50 mg tablet, 30 | has TPUU | True | Naltrexone (Apo) 50 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR